We would like to thank Dr. Milano et al. for the point they made on the possible role of drug-induced immune response occurring during treatment with either anti-VEGF or anti-EGFR agents
Formica, V., Zaniboni, A. (2016). Response from Drs. Formica/Zaniboni to Dr. Milano. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 78(2), 247-247 [10.1007/s00280-016-3082-y].
Response from Drs. Formica/Zaniboni to Dr. Milano
Formica, V.;
2016-01-01
Abstract
We would like to thank Dr. Milano et al. for the point they made on the possible role of drug-induced immune response occurring during treatment with either anti-VEGF or anti-EGFR agentsFile in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
s00280-016-3082-y.pdf
solo utenti autorizzati
Tipologia:
Versione Editoriale (PDF)
Licenza:
Copyright dell'editore
Dimensione
345.28 kB
Formato
Adobe PDF
|
345.28 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
